Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Dermatology  |  Family Medicine

Search Medical Condition
Please enter condition
Please choose location from dropdown

Eczema (Atopic Dermatitis) Clinical Trials

A listing of Eczema (Atopic Dermatitis) medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (157) clinical trials

The purpose of the trial is to test if the trial drug, tralokinumab, is better than placebo or ‘dummy treatment’ at treating moderate to severe atopic dermatitis. This will be judged by a range of assessments that rate the severity and extent of atopic dermatitis, itch and several other symptoms, ...

Phase

The main purpose of this study is to compare the safety, efficacy, and tolerability of a once-daily topical application of IDP-123 Lotion compared to the IDP-123 Vehicle Lotion in subjects with moderate to severe acne. Subjects must be at least 9 years of age or older and generally healthy. IDP-123 ...

Phase

BMX-010 is thought to treat a wide variety of inflammatory disorders. The main purpose of this study is to learn about the safety of the study drug. The primary purpose is to determine how much and how often BMX-010 can be safely given to patients with AD or PS. We ...

Phase

A Prospective, vehicle-controlled, double blind, multicenter, randomized phase II study of B244 delivered as a topical spray to determine safety in subjects with mild to moderate atopic dermatitis.

Phase N/A

If you have been diagnosed with moderate to severe eczema, also known as Atopic Dermatitis (AD), you may qualify to participate in a research study evaluating an investigational gel medication.   To qualify you must: • Be 12 years of age or older • Have relatively stable AD (i.e. your ...

Phase N/A

Study is for an investigational eczema medication that is delivered as an injection at the doctors office.

Phase

If you are 18 years or older and struggle with eczema, you may qualify for a new clinical research study. The study is for an investigational eczema medication that is delivered as an injection at the doctor's office.

Phase

Participants with atopic dermatitis and eczema conditions will be given a lotion to use over the course of 4 weeks. They will be asked to return to the clinic at weeks 2 and 4 where assessments will be done to see how effective the lotion is.

Phase N/A

The primary objective for part A of the study is to characterize the safety and pharmacokinetics (PK) of dupilumab administered as a single dose in pediatric patients, 6 months to less than 6 years of age with severe atopic dermatitis (AD). The primary objective for part B of the study ...

Phase